Temazepam (temazepam)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Temazepam is a benzodiazepine.
Temazepam shares the actions of other benzodiazepines and is used as a hypnotic agent in the short-term treatment of insomnia generally for periods not exceeding 7-10 days in duration. The failure of insomnia to remit after 7-10 days of temazepam therapy may indicate the presence of an underlying psychiatric and/or medical condition. Prolonged use of hypnotics is usually not indicated and should be undertaken only upon further evaluation of the patient.
The possibility that insomnia may be a symptom of an underlying condition for which there may be a more specific treatment should be considered.
Generic name: temazepam
Pronunciation: (teh-MAZ-eh-pam)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Temazepam
Indications
The following indications are listed for Temazepam:
- Insomnia
Also known as: Agrypnia, Ahypnia.
Dosing
Dosage of temazepam must be individualized, and the smallest effective dosage should be used (especially in geriatric or debilitated patients or in those with liver disease or low serum albumin). Prolonged administration of temazepam should be avoided.
The usual adult dose of temazepam is 15 mg; however, 7.5 mg may be adequate in some patients, while others may require 22.5 or 30 mg. For transient insomnia, 7.5 mg may be adequate to improve sleep latency. In geriatric or debilitated patients, an initial dose of 7.5 mg should be used until individual response is determined. In patients who have received prolonged (e.g., for several months) temazepam therapy at dosages exceeding 15 mg daily, abrupt discontinuance of the drug should be avoided since manifestations of withdrawal can be precipitated; if the drug is to be discontinued in such patients, it is recommended that dosage be gradually tapered.
Temazepam is administered orally at bedtime.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.